In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Lutavit H2 Drug Master File in Korea (Lutavit H2 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Lutavit H2. The MFDS reviews the Lutavit H2 KDMF as part of the drug registration process and uses the information provided in the Lutavit H2 KDMF to evaluate the safety and efficacy of the drug.
After submitting a Lutavit H2 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Lutavit H2 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Lutavit H2 suppliers with KDMF on PharmaCompass.